Central neurotransmitter substances and aging: a review.
Available evidence suggests that age is an important determinant of the levels of neurotransmitters and their associated enzymes and metabolites in some regions of the brain. Alterations at the synaptic level, or selective cell death in the brain, or both, may be implicated in progressive loss of function, behavioral changes and the onset of age-related diseases. Stimulation of hypothalamic neuroendocrine transducer cells by agents that alter neurotransmitter metabolism might provide some measure of control of the process of aging.
D000109:Acetylcholine / Q000378:metabolism; D000368:Aged; D000375:Aging; D000596:Amino Acids / Q000378:metabolism; D001519:Behavior / Q000187:drug effects; D001921:Brain / Q000378:metabolism* / Q000502:physiology; D002395:Catecholamines / Q000378:metabolism; D005246:Feedback; D006706:Homeostasis; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D007858:Learning; D008568:Memory; D018377:Neurotransmitter Agents / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects
D000596:Amino Acids; D002395:Catecholamines; D018377:Neurotransmitter Agents; D012701:Serotonin; D000109:Acetylcholine